Charles E. Riggs
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Oncology top 5%
- Cancer Treatment and Pharmacology
Papers in
- Oncology 26
- Cancer Treatment and Pharmacology 11
- Lung Cancer Research Studies 6
- Peptidase Inhibition and Analysis 4
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Nicholas R. Bachur (8 shared papers)Robert S. Benjamin (5 shared papers)William M. Mendenhall (11 shared papers)Charles M. Mendenhall (2 shared papers)Nancy P. Mendenhall (2 shared papers)John W. Werning (2 shared papers)Douglas B. Villaret (2 shared papers)Arthur A. Serpick (3 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (5 papers)Journal of Clinical Oncology (4 papers)European Journal of Applied Physiology (3 papers)Journal of Pharmacology and Experimental Therapeutics (2 papers)Head & Neck (2 papers)
- Partner nations
- United StatesUnited KingdomMalaysia
In The Last Decade
Charles E. Riggs
61 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 114
- Otorhinolaryngology 120
- Oncology 522
- Cardiology and Cardiovascular Medicine 368
- Clinical Biochemistry 116
- Biophysics 55
Countries citing papers authored by Charles E. Riggs
This map shows the geographic impact of Charles E. Riggs's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charles E. Riggs with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charles E. Riggs more than expected).
Fields of papers citing papers by Charles E. Riggs
This network shows the impact of papers produced by Charles E. Riggs. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charles E. Riggs. The network helps show where Charles E. Riggs may publish in the future.
Co-authors
The 25 scholars most cited alongside Charles E. Riggs, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Plasma pharmacokinetics of adriamycin and its metabolites in humans with normal hepatic and renal function. | 1977 | 196 |
| 2 | 1973 | 190 | |
| 3 | 2009 | 164 | |
| 4 | 2001 | 108 | |
| 5 | 2005 | 85 | |
| 6 | 1977 | 79 | |
| 7 | 1990 | 69 | |
| 8 | 1977 | 68 | |
| 9 | 2006 | 53 | |
| 10 | 2003 | 51 | |
| 11 | 1988 | 50 | |
| 12 | Managing cetuximab hypersensitivity-infusion reactions: incidence, risk factors, prevention, and retreatment. | 2010 | 40 |
| 13 | 2010 | 36 | |
| 14 | Phase I trial of lonidamine with whole body hyperthermia in advanced cancer. | 1988 | 29 |
| 15 | 1990 | 28 | |
| 16 | 2004 | 27 | |
| 17 | 1997 | 27 | |
| 18 | 2002 | 26 | |
| 19 | 2009 | 23 | |
| 20 | 1979 | 23 |
About Charles E. Riggs
Charles E. Riggs is a scholar working on Oncology, Molecular Biology, Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Otorhinolaryngology, having authored 63 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chemotherapy-induced cardiotoxicity and mitigation (11 papers), Cancer Treatment and Pharmacology (11 papers), Head and Neck Cancer Studies (8 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (5 papers), Acute Lymphoblastic Leukemia research (4 papers), Peptidase Inhibition and Analysis (4 papers) and Chronic Lymphocytic Leukemia Research (4 papers). The work is most often cited by research in Otorhinolaryngology (120 citations), Oncology (522 citations), Cardiology and Cardiovascular Medicine (368 citations), Clinical Biochemistry (116 citations) and Biophysics (55 citations). Charles E. Riggs has collaborated with scholars based in United States, United Kingdom and Malaysia. Frequent co-authors include Nicholas R. Bachur, Robert S. Benjamin, William M. Mendenhall, Charles M. Mendenhall, Nancy P. Mendenhall, John W. Werning, Douglas B. Villaret, Arthur A. Serpick, Robert J. Amdur and Patrick W. Hitchon. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of Clinical Oncology, European Journal of Applied Physiology, Journal of Pharmacology and Experimental Therapeutics and Head & Neck.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.